Related Experiment Video
Updated: Jun 13, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
[Increased cardiovascular risk in HIV patients]
1Maastricht Universitair Medisch Centrum, afd Algemene Interne Geneeskunde, Maastricht, The Netherlands. t.wierema@mumc.nl
Insights
Effective HIV treatments increase cardiovascular disease risk. Current guidelines suggest higher lipid targets for HIV patients, but drug interactions require careful consideration.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Context:
- Effective antiretroviral therapies (ART) for human immunodeficiency virus (HIV) have shifted mortality causes in patients towards non-HIV-related conditions.
- HIV infection and its treatment are independently associated with an increased risk of cardiovascular disease (CVD).
- HIV-associated atherosclerosis and treatment-induced dyslipidemia and insulin resistance contribute to elevated CVD risk.
Purpose:
- To highlight the increased cardiovascular disease risk in patients with HIV.
- To discuss the current discrepancies in cardiovascular risk management guidelines for HIV patients.
- To emphasize the need for careful consideration of drug interactions between statins and antiretroviral agents.
Summary:
- HIV patients face a higher risk of cardiovascular disease due to the virus itself and its treatment, including highly active antiretroviral therapy (HAART).
- While standard CVD risk factor management applies, current guidelines often set higher lipid targets for HIV-positive individuals.
- Potential interactions between specific statins and antiretroviral drugs necessitate careful clinical management.
Impact:
- This research underscores the importance of tailored cardiovascular risk management strategies for individuals living with HIV.
- It calls for a re-evaluation of current clinical practice guidelines regarding lipid targets in HIV patients.
- Highlights the critical need for clinicians to be aware of and manage potential drug-drug interactions in this population.
Abstract:
Effective antiretroviral treatments for HIV have led to patients with HIV more often dying from causes not associated with HIV, such as cardiovascular disease. HIV patients have a higher risk of cardiovascular disease, due to the infection as well as its treatment. The HIV virus causes atherosclerosis, and highly active antiretroviral therapy (HAART) leads to dyslipidaemia and insulin resistance. In the treatment of cardiovascular risk factors in HIV patients, the same treatment aims should apply as in patients without HIV; in the current practice guidelines, however, higher target values for lipids are applied for patients with HIV. When treating cardiovascular risk factors, interactions between certain statins and antiretroviral agents should be taken into consideration.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Retrovirus Life Cycles
Coronary Artery Disease I: Introduction